SUBSTITUTED PYRIMIDINETHIOALKYL OR ALKYLESTER COMPOUNDS AND METHOD OF INHIBITION OF VIRAL REVERSE TRANSCRIPTASE ACTIVITY

organic chemistry, biochemistry, virology. SUBSTANCE: invention relates to novel substituted pyrimidinethioalkyl or alkylester compounds, their pharmaceutically acceptable salts, hydrates, N-oxides and method of inhibition of viral reverse transcriptase activity. Proposed compounds can be used in tr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DONN G. VISHKA, MAJKL DZH. MERFI, RICHARD A. N'JUDZHENT, RICHARD S. TOMAS, DEHVID R. GREJBER, STIVEN TOMAS SHLJAKHTER, GARI DZH. KLIK, DZHOEL MORRIS
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	DONN G. VISHKA MAJKL DZH. MERFI RICHARD A. N'JUDZHENT RICHARD S. TOMAS DEHVID R. GREJBER STIVEN TOMAS SHLJAKHTER GARI DZH. KLIK DZHOEL MORRIS
description	organic chemistry, biochemistry, virology. SUBSTANCE: invention relates to novel substituted pyrimidinethioalkyl or alkylester compounds, their pharmaceutically acceptable salts, hydrates, N-oxides and method of inhibition of viral reverse transcriptase activity. Proposed compounds can be used in treatment of HIV-infected patients. Proposed compounds correspond to the general structural formula (I) where m = 0 or 1; R1 is taken among the group consisting of: -C=CH, -CO2R53, -CONR54R55 or residues of compounds of the formulas (A) , (B) and (C) where radical values are given in the invention claim. Method of inhibition of activity of viral reverse transcriptase involves administration to patients of effective dose of compound of the formula (I). EFFECT: new compounds indicated above, improved method of inhibition. 20 cl, 13 tbl
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2167155C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2167155C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2167155C23</originalsourceid><addsrcrecordid>eNqNikEOgjAQALl4MOof9gMewKDn0i5hI7RkuyXhRIipJ6MkePD5ovEBnmYmmXXy8qHwQhIEDbQ9U0OGLEpFTtXnvgbH8BX0ggzaNa0L1nhQ1kCzfM6AK4FsRQUJOfupjljVwNghewRhZb1makUtpbRQR9Jvk9V1vM1x9-MmgRJFV_s4PYY4T-Ml3uNz4JClx1Oa5zo7_LG8AczHOsA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED PYRIMIDINETHIOALKYL OR ALKYLESTER COMPOUNDS AND METHOD OF INHIBITION OF VIRAL REVERSE TRANSCRIPTASE ACTIVITY</title><source>esp@cenet</source><creator>DONN G. VISHKA ; MAJKL DZH. MERFI ; RICHARD A. N'JUDZHENT ; RICHARD S. TOMAS ; DEHVID R. GREJBER ; STIVEN TOMAS SHLJAKHTER ; GARI DZH. KLIK ; DZHOEL MORRIS</creator><creatorcontrib>DONN G. VISHKA ; MAJKL DZH. MERFI ; RICHARD A. N'JUDZHENT ; RICHARD S. TOMAS ; DEHVID R. GREJBER ; STIVEN TOMAS SHLJAKHTER ; GARI DZH. KLIK ; DZHOEL MORRIS</creatorcontrib><description>organic chemistry, biochemistry, virology. SUBSTANCE: invention relates to novel substituted pyrimidinethioalkyl or alkylester compounds, their pharmaceutically acceptable salts, hydrates, N-oxides and method of inhibition of viral reverse transcriptase activity. Proposed compounds can be used in treatment of HIV-infected patients. Proposed compounds correspond to the general structural formula (I) where m = 0 or 1; R1 is taken among the group consisting of: -C=CH, -CO2R53, -CONR54R55 or residues of compounds of the formulas (A) , (B) and (C) where radical values are given in the invention claim. Method of inhibition of activity of viral reverse transcriptase involves administration to patients of effective dose of compound of the formula (I). EFFECT: new compounds indicated above, improved method of inhibition. 20 cl, 13 tbl</description><edition>7</edition><language>eng ; rus</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010520&DB=EPODOC&CC=RU&NR=2167155C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010520&DB=EPODOC&CC=RU&NR=2167155C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DONN G. VISHKA</creatorcontrib><creatorcontrib>MAJKL DZH. MERFI</creatorcontrib><creatorcontrib>RICHARD A. N'JUDZHENT</creatorcontrib><creatorcontrib>RICHARD S. TOMAS</creatorcontrib><creatorcontrib>DEHVID R. GREJBER</creatorcontrib><creatorcontrib>STIVEN TOMAS SHLJAKHTER</creatorcontrib><creatorcontrib>GARI DZH. KLIK</creatorcontrib><creatorcontrib>DZHOEL MORRIS</creatorcontrib><title>SUBSTITUTED PYRIMIDINETHIOALKYL OR ALKYLESTER COMPOUNDS AND METHOD OF INHIBITION OF VIRAL REVERSE TRANSCRIPTASE ACTIVITY</title><description>organic chemistry, biochemistry, virology. SUBSTANCE: invention relates to novel substituted pyrimidinethioalkyl or alkylester compounds, their pharmaceutically acceptable salts, hydrates, N-oxides and method of inhibition of viral reverse transcriptase activity. Proposed compounds can be used in treatment of HIV-infected patients. Proposed compounds correspond to the general structural formula (I) where m = 0 or 1; R1 is taken among the group consisting of: -C=CH, -CO2R53, -CONR54R55 or residues of compounds of the formulas (A) , (B) and (C) where radical values are given in the invention claim. Method of inhibition of activity of viral reverse transcriptase involves administration to patients of effective dose of compound of the formula (I). EFFECT: new compounds indicated above, improved method of inhibition. 20 cl, 13 tbl</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNikEOgjAQALl4MOof9gMewKDn0i5hI7RkuyXhRIipJ6MkePD5ovEBnmYmmXXy8qHwQhIEDbQ9U0OGLEpFTtXnvgbH8BX0ggzaNa0L1nhQ1kCzfM6AK4FsRQUJOfupjljVwNghewRhZb1makUtpbRQR9Jvk9V1vM1x9-MmgRJFV_s4PYY4T-Ml3uNz4JClx1Oa5zo7_LG8AczHOsA</recordid><startdate>20010520</startdate><enddate>20010520</enddate><creator>DONN G. VISHKA</creator><creator>MAJKL DZH. MERFI</creator><creator>RICHARD A. N'JUDZHENT</creator><creator>RICHARD S. TOMAS</creator><creator>DEHVID R. GREJBER</creator><creator>STIVEN TOMAS SHLJAKHTER</creator><creator>GARI DZH. KLIK</creator><creator>DZHOEL MORRIS</creator><scope>EVB</scope></search><sort><creationdate>20010520</creationdate><title>SUBSTITUTED PYRIMIDINETHIOALKYL OR ALKYLESTER COMPOUNDS AND METHOD OF INHIBITION OF VIRAL REVERSE TRANSCRIPTASE ACTIVITY</title><author>DONN G. VISHKA ; MAJKL DZH. MERFI ; RICHARD A. N'JUDZHENT ; RICHARD S. TOMAS ; DEHVID R. GREJBER ; STIVEN TOMAS SHLJAKHTER ; GARI DZH. KLIK ; DZHOEL MORRIS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2167155C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2001</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DONN G. VISHKA</creatorcontrib><creatorcontrib>MAJKL DZH. MERFI</creatorcontrib><creatorcontrib>RICHARD A. N'JUDZHENT</creatorcontrib><creatorcontrib>RICHARD S. TOMAS</creatorcontrib><creatorcontrib>DEHVID R. GREJBER</creatorcontrib><creatorcontrib>STIVEN TOMAS SHLJAKHTER</creatorcontrib><creatorcontrib>GARI DZH. KLIK</creatorcontrib><creatorcontrib>DZHOEL MORRIS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DONN G. VISHKA</au><au>MAJKL DZH. MERFI</au><au>RICHARD A. N'JUDZHENT</au><au>RICHARD S. TOMAS</au><au>DEHVID R. GREJBER</au><au>STIVEN TOMAS SHLJAKHTER</au><au>GARI DZH. KLIK</au><au>DZHOEL MORRIS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED PYRIMIDINETHIOALKYL OR ALKYLESTER COMPOUNDS AND METHOD OF INHIBITION OF VIRAL REVERSE TRANSCRIPTASE ACTIVITY</title><date>2001-05-20</date><risdate>2001</risdate><abstract>organic chemistry, biochemistry, virology. SUBSTANCE: invention relates to novel substituted pyrimidinethioalkyl or alkylester compounds, their pharmaceutically acceptable salts, hydrates, N-oxides and method of inhibition of viral reverse transcriptase activity. Proposed compounds can be used in treatment of HIV-infected patients. Proposed compounds correspond to the general structural formula (I) where m = 0 or 1; R1 is taken among the group consisting of: -C=CH, -CO2R53, -CONR54R55 or residues of compounds of the formulas (A) , (B) and (C) where radical values are given in the invention claim. Method of inhibition of activity of viral reverse transcriptase involves administration to patients of effective dose of compound of the formula (I). EFFECT: new compounds indicated above, improved method of inhibition. 20 cl, 13 tbl</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; rus
recordid	cdi_epo_espacenet_RU2167155C2
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	SUBSTITUTED PYRIMIDINETHIOALKYL OR ALKYLESTER COMPOUNDS AND METHOD OF INHIBITION OF VIRAL REVERSE TRANSCRIPTASE ACTIVITY
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A45%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DONN%20G.%20VISHKA&rft.date=2001-05-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2167155C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true